Oncology & Cancer

Age at menopause, hormone therapy linked to BCC risk

(HealthDay)—Late age at natural menopause and menopausal hormone therapy (MHT) use are associated with increased risk of basal cell carcinoma (BCC), according to a study published online Nov. 2 in the Journal of Clinical ...

Oncology & Cancer

Case of basal cell carcinoma described within port wine stain

(HealthDay)—A case of basal cell carcinoma (BCC) has been described within a port wine stain (PWS), with no preceding treatment, according to a case report published in the October issue of The Journal of Dermatology.

Oncology & Cancer

New skin cancer drug approved by FDA

(HealthDay)—A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration.

Medications

Odomzo approved for recurring basal cell carcinoma

(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.

Medications

FDA approves odomzo for recurring basal cell carcinoma

(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat patients with locally advanced basal cell carcinoma that has returned despite surgery or radiation, or who are not candidates ...

Oncology & Cancer

Multiphoton microscopy reveals features of basal cell carcinoma

(HealthDay)—Noninvasive multiphoton microscopy (MPM) imaging can reveal characteristic features of basal cell carcinoma (BCC) in human skin, according to a study published online April 24 in JAMA Dermatology. The research ...

page 10 from 17